'Magic mushroom' compound may work just as well as antidepressants, small study finds


Jul 2, 2020
Good news that alternative treatments are being studied seriously.

These studies have been showing up for many years so why has the FDA not been doing more over many years to research these alternative treatments that do not require to be taken for extended time frames ?


Will big pharma put pressure to spin this another way to protect its anti depressant drugs which are expensive and mostly require patients to take these for life and have severe withdrawal / suicidal effects if stopped

It has been established that big pharma anti depressant drugs are linked to suicide

Even Psychology Professor Peter Jordan ended up feeling suicidal after taking big pharma drugs himself for many years

Dr Peterson took Klonopin as prescribed by his Doctor in the United States; this is the case for the vast majority of people who end up with a problem with benzodiazepines such as Klonopin (Clonazepam), Valium (Diazepam), Ativan (Lorazepam) and Xanax (Alprazolam), to name the most common.
This case demonstrates that even an esteemed Clinical Psychologist with a wealth of experience and knowledge can place their trust in Doctors who may not be aware of the risks that benzodiazepines carry.
In the benzodiazepine recovery community, this is an Iatrogenic problem - i.e. a medical problem caused by a Doctor.
What became clear from this latest video from Mikhaila Peterson, is that Dr Peterson had been taking Klonopin for longer than previously stated. The dosage had been increased in 2019 when his wife became gravely ill with a form of cancer, which Dr Peterson quite understandably needed extra support to manage along with his plethora of projects and responsibilities.
The use of the term ‘low dose’ is in fact, erroneous. There is no such thing as a low dose of Klonopin, as it is currently prescribed. Consider these equivalencies.
Based on the table below, 1mg of Klonopin would be equal to 20mg of Valium.
The pharmaceutical companies, as pointed out by the Benzodiazepine Information Coalition, use this as marketing ploy to make the medications sound less potent.
Source: https://www.benzo.org.uk/bzequiv.htm
Dr Peterson was also on an SSRI medication for a long time, as well as Wellbutrin and has been open about his history of depression.

A reexamination of old data for Paxil found that the antidepressant is more dangerous than the authors let on. How much harm has been done in the 14 years since it was published?

The reanalysis, published in the scientific journal BMJ, found that the study, underwritten by the drug’s maker, GlaxoSmithKline (or GSK), created a false picture of safety partly by misclassifying suicidal acts (such as taking 80 Tylenol) as less-alarming behavior or side effects. Other researchers who have looked at Study 329’s data have concluded likewise.

Count this as shocking but unsurprising, for GSK has been admonished and fined many times since 2001, including once for $3 billion, for exaggerating Paxil’s safety and marketing it improperly for use in adolescents. Yet this BMJ study deals an especially sharp blow, for it’s only rarely that researchers are able to crack open the tightly sealed file cabinets of drugmakers and look at raw trial data. This illustrates why they want to do so: It appears to be a direct demonstration of how a company and researchers can misinterpret the data to make a bad drug look good.

Last edited: